Breaking News Instant updates and real-time market news.

TAP

Molson Coors

$53.37 /

-0.14 (-0.26%)

09:05
01/06/20
01/06
09:05
01/06/20
09:05

Molson Coors adding forum selection provision 'interesting,' says Evercore ISI

Evercore ISI analyst Robert Ottenstein said in a note to investors published on Friday that Molson Coors "interestingly" added a forum selection provision to its bylaws. Many companies have adopted exclusive forum bylaws in recent years and adopting such an exclusive forum provision "does not necessarily mean that a transaction is imminent," said Ottenstein in Friday's note. However, he also pointed out that outside counsel has previously suggested that it makes sense for companies that see potential M&A in the future to protect themselves with such a provision since multi-state lawsuits "have accompanied 90+% of large M&A over the last few years." Ottenstein has an Outperform rating on Molson Coors shares.

TAP Molson Coors
$53.37 /

-0.14 (-0.26%)

11/26/19
Fly Intel: Top five analyst downgrades
11/26/19 BMO Capital
Molson Coors downgraded to Market Perform from Outperform at BMO Capital
11/25/19
Fly Intel: Top five analyst downgrades
11/25/19 Barclays
Molson Coors downgraded to Equal Weight from Overweight at Barclays

TODAY'S FREE FLY STORIES

Hot Stocks
Several Google services suffered outages Thursday night » 05:56
09/25/20
09/25
05:56
09/25/20
05:56
GOOG

Alphabet

$1,428.38 /

+12.63 (+0.89%)

, GOOGL

Alphabet Class A

$1,422.43 /

+12.9 (+0.92%)

Several Google services,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOOG Alphabet
$1,428.38 /

+12.63 (+0.89%)

GOOGL Alphabet Class A
$1,422.43 /

+12.9 (+0.92%)

GOOG Alphabet
$1,428.38 /

+12.63 (+0.89%)

09/24/20 Morgan Stanley
Alphabet price target raised to $1,800 after consumer survey at Morgan Stanley
09/18/20 Morgan Stanley
AES Corp. price target raised to $23.50 from $19 at Morgan Stanley
09/14/20 KeyBanc
Alphabet initiated with an Overweight at KeyBanc
08/25/20 UBS
Alphabet price target raised to $1,970 from $1,600 at UBS
GOOGL Alphabet Class A
$1,422.43 /

+12.9 (+0.92%)

09/24/20 Morgan Stanley
Alphabet price target raised to $1,800 after consumer survey at Morgan Stanley
09/18/20 Morgan Stanley
AES Corp. price target raised to $23.50 from $19 at Morgan Stanley
09/15/20
Fly Intel: Top five analyst initiations
09/14/20 KeyBanc
Alphabet initiated with an Overweight at KeyBanc
GOOG Alphabet
$1,428.38 /

+12.63 (+0.89%)

GOOGL Alphabet Class A
$1,422.43 /

+12.9 (+0.92%)

GOOG Alphabet
$1,428.38 /

+12.63 (+0.89%)

GOOGL Alphabet Class A
$1,422.43 /

+12.9 (+0.92%)

GOOG Alphabet
$1,428.38 /

+12.63 (+0.89%)

GOOGL Alphabet Class A
$1,422.43 /

+12.9 (+0.92%)

GOOGL Alphabet Class A
$1,422.43 /

+12.9 (+0.92%)

GOOGL Alphabet Class A
$1,422.43 /

+12.9 (+0.92%)

Syndicate
GeoVax Labs 2.56M share IPO priced at $5.00 » 05:55
09/25/20
09/25
05:55
09/25/20
05:55
GOVX

GeoVax Labs

$0.00 /

+ (+0.00%)

Maxim acted as lead book…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
GOVX GeoVax Labs
$0.00 /

+ (+0.00%)

GOVX GeoVax Labs
$0.00 /

+ (+0.00%)

Conference/Events
European Association for the Study of Diabetes to hold a virtual annual meeting » 05:55
09/25/20
09/25
05:55
09/25/20
05:55
ABT

Abbott

$100.91 /

-1.81 (-1.76%)

, AMRN

Amarin

$3.64 /

-0.035 (-0.95%)

, AMYT

Amryt Pharma

$11.57 /

-0.48 (-3.98%)

, AZN

AstraZeneca

$54.18 /

-1.495 (-2.69%)

, BAYRY

Bayer

$0.00 /

+ (+0.00%)

, DXCM

DexCom

$382.64 /

-2.39 (-0.62%)

, GILD

Gilead

$62.26 /

-0.85 (-1.35%)

, LLY

Eli Lilly

$148.89 /

-1 (-0.67%)

, MDT

Medtronic

$101.30 /

-0.52 (-0.51%)

, MRK

Merck

$83.17 /

+0.54 (+0.65%)

, NVO

Novo Nordisk

$68.25 /

-1.195 (-1.72%)

, NVS

Novartis

$86.30 /

-1.15 (-1.32%)

, PODD

Insulet

$216.60 /

-11.07 (-4.86%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

, SNY

Sanofi

$50.75 /

+0.15 (+0.30%)

, TNDM

TNDM

/

+

, VTVT

vTv Therapeutics

$1.73 /

-0.09 (-4.95%)

56th Virtual Annual…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABT Abbott
$100.91 /

-1.81 (-1.76%)

AMRN Amarin
$3.64 /

-0.035 (-0.95%)

AMYT Amryt Pharma
$11.57 /

-0.48 (-3.98%)

AZN AstraZeneca
$54.18 /

-1.495 (-2.69%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

DXCM DexCom
$382.64 /

-2.39 (-0.62%)

GILD Gilead
$62.26 /

-0.85 (-1.35%)

LLY Eli Lilly
$148.89 /

-1 (-0.67%)

MDT Medtronic
$101.30 /

-0.52 (-0.51%)

MRK Merck
$83.17 /

+0.54 (+0.65%)

NVO Novo Nordisk
$68.25 /

-1.195 (-1.72%)

NVS Novartis
$86.30 /

-1.15 (-1.32%)

PODD Insulet
$216.60 /

-11.07 (-4.86%)

RHHBY Roche
$0.00 /

+ (+0.00%)

SNY Sanofi
$50.75 /

+0.15 (+0.30%)

TNDM TNDM
/

+

VTVT vTv Therapeutics
$1.73 /

-0.09 (-4.95%)

ABT Abbott
$100.91 /

-1.81 (-1.76%)

09/11/20 Wolfe Research
Abbott initiated with an Outperform at Wolfe Research
08/31/20 Credit Suisse
Abbott price target raised to $136 from $109 at Credit Suisse
08/28/20 Canaccord
Hospital service channel shares weakness a buying opportunity, says Canaccord
08/28/20 Piper Sandler
COVID-19 test provider selloff on Abbott approval overdone, says Piper
AMRN Amarin
$3.64 /

-0.035 (-0.95%)

09/08/20 Cantor Fitzgerald
Amarin price target lowered to $15 from $35 at Cantor Fitzgerald
09/04/20 Northland
Amarin generic competitors to be constrained by supply chains, says Northland
09/04/20 Goldman Sachs
Goldman sees Amarin investor focus shifting to 'significant' Europe opportunity
09/03/20 Stifel
Amarin price target lowered to $5 from $8 at Stifel
AMYT Amryt Pharma
$11.57 /

-0.48 (-3.98%)

07/20/20
Fly Intel: Top five analyst initiations
07/20/20 Canaccord
Amryt Pharma initiated with a Buy at Canaccord
07/09/20
Fly Intel: Top five analyst initiations
07/08/20 Cantor Fitzgerald
Cantor Fitzgerald starts Amryt at Overweight, sees number of catalysts upcoming
AZN AstraZeneca
$54.18 /

-1.495 (-2.69%)

09/23/20 Oddo BHF
AstraZeneca upgraded to Buy from Reduce at Oddo BHF
09/18/20 Societe Generale
Societe Generale ups AstraZeneca target, sees earnings tripling in five years
09/09/20 Piper Sandler
Piper sees 'no readthrough' to Altimmune from AstraZeneca COVID trial hold
09/09/20 SVB Leerink
AstraZeneca pause 'a mixed blessing for Moderna, others, says SVB Leerink
BAYRY Bayer
$0.00 /

+ (+0.00%)

09/14/20 Morgan Stanley
Bayer price target lowered to EUR 82 from EUR 83 at Morgan Stanley
09/10/20
Fly Intel: Top five analyst initiations
09/10/20 Roth Capital
Dare Bioscience resumed with a Buy at Roth Capital
09/09/20 BMO Capital
Bayer initiated with a Market Perform at BMO Capital
DXCM DexCom
$382.64 /

-2.39 (-0.62%)

08/11/20 Piper Sandler
Medtronic acquisition of Companion 'a smart decision,' says Piper Sandler
07/29/20 SVB Leerink
DexCom price target raised to $485 from $465 at SVB Leerink
07/29/20 Guggenheim
DexCom price target raised to $500 from $395 at Guggenheim
07/29/20 Canaccord
DexCom price target raised to $500 from $435 at Canaccord
GILD Gilead
$62.26 /

-0.85 (-1.35%)

09/24/20 H.C. Wainwright
Durect study designed to support full approval, says H.C. Wainwright
09/20/20 Citi
Immunomedics presents at ESMO, readouts exceeded expectations, says Citi
09/18/20 RBC Capital
Gilead price target raised to $86 from $82 at RBC Capital
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
LLY Eli Lilly
$148.89 /

-1 (-0.67%)

09/21/20 Morgan Stanley
Eli Lilly's Verzenio 'clear winner' over Pfizer's Ibrance, says Morgan Stanley
09/16/20 Canaccord
Eli Lilly COVID-19 data bodes well for Regeneron, says Canaccord
09/16/20 Goldman Sachs
Eli Lilly COVID-19 antibody data 'encouraging,' says Goldman Sachs
09/07/20 Piper Sandler
Early approval of Blueprint's Gavreto 'a nice surprise,' says Piper Sandler
MDT Medtronic
$101.30 /

-0.52 (-0.51%)

09/11/20 Wolfe Research
Medtronic initiated with a Peer Perform at Wolfe Research
08/26/20 Raymond James
Medtronic price target raised to $115 from $107 at Raymond James
08/26/20 BTIG
Medtronic price target raised to $111 from $102 at BTIG
08/26/20 Citi
Medtronic price target raised to $120 from $108 at Citi
MRK Merck
$83.17 /

+0.54 (+0.65%)

09/24/20 Roth Capital
Merck data suggests 'another shot on goal' for Jounce, says Roth Capital
09/22/20 Stifel
Seattle Genetics price target raised to $165 from $145 at Stifel
09/21/20 Piper Sandler
Regeneron's Libtayo delivered results on par with Keytruda, says Piper Sandler
09/15/20 SVB Leerink
Seattle Genetics price target raised to $185 from $173 at SVB Leerink
NVO Novo Nordisk
$68.25 /

-1.195 (-1.72%)

08/18/20 UBS
Novo Nordisk price target lowered to DKK 415 from DKK 425 at UBS
08/03/20 Morgan Stanley
Novo Nordisk price target lowered to DKK 425 from DKK 435 at Morgan Stanley
07/06/20 BofA
Novo Nordisk downgraded to Neutral from Buy at BofA
06/05/20 JPMorgan
JPMorgan backs Overweight on Novo Nordisk after STEP data
NVS Novartis
$86.30 /

-1.15 (-1.32%)

09/24/20 Barclays
Regenxbio price target lowered to $79 from $88 at Barclays
09/23/20 BMO Capital
Ionis Pharmaceuticals' Spinraza benefits from Novartis' AVXS-101 delay, says BMO
09/23/20 SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
09/23/20 Oddo BHF
Novartis downgraded to Neutral from Buy at Oddo BHF
PODD Insulet
$216.60 /

-11.07 (-4.86%)

08/11/20 Piper Sandler
Medtronic acquisition of Companion 'a smart decision,' says Piper Sandler
08/07/20 Stephens
Insulet price target raised to $230 from $165 at Stephens
08/07/20 Citi
Insulet price target raised to $255 from $200 at Citi
08/06/20 Piper Sandler
Insulet price target raised to $260 from $235 at Piper Sandler
RHHBY Roche
$0.00 /

+ (+0.00%)

09/23/20 SVB Leerink
Ionis should trade up, Regenxbio down after Novartis update, says SVB Leerink
09/23/20 BMO Capital
Blueprint Medicines price target raised to $113 from $105 at BMO Capital
09/23/20 Oddo BHF
Roche downgraded to Reduce from Buy at Oddo BHF
09/21/20 H.C. Wainwright
Turning Point price target raised to $100 from $88 at H.C. Wainwright
SNY Sanofi
$50.75 /

+0.15 (+0.30%)

09/21/20 Piper Sandler
Regeneron's Libtayo delivered results on par with Keytruda, says Piper Sandler
09/14/20 Roth Capital
Immunic has 'significant' opportunity in RRMS, says Roth Capital
08/24/20 SVB Leerink
SVB Leerink continues to view Alexion as good M&A fit for number of suitors
08/19/20 Stifel
Principia Biopharma downgraded to Hold from Buy at Stifel
TNDM TNDM
/

+

08/20/20
Fly Intel: Top five analyst initiationsNewPage
08/20/20 Wells Fargo
Tandem Diabetes initiated with an Overweight at Wells Fargo
08/11/20 Piper Sandler
Medtronic acquisition of Companion 'a smart decision,' says Piper Sandler
07/31/20 Craig-Hallum
Tandem Diabetes price target raised to $140 from $102 at Craig-Hallum
VTVT vTv Therapeutics
$1.73 /

-0.09 (-4.95%)

02/10/20 H.C. Wainwright
vTv Therapeutics price target raised to $6 from $5 at H.C. Wainwright
ABT Abbott
$100.91 /

-1.81 (-1.76%)

AMRN Amarin
$3.64 /

-0.035 (-0.95%)

AZN AstraZeneca
$54.18 /

-1.495 (-2.69%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

DXCM DexCom
$382.64 /

-2.39 (-0.62%)

GILD Gilead
$62.26 /

-0.85 (-1.35%)

LLY Eli Lilly
$148.89 /

-1 (-0.67%)

MDT Medtronic
$101.30 /

-0.52 (-0.51%)

MRK Merck
$83.17 /

+0.54 (+0.65%)

NVO Novo Nordisk
$68.25 /

-1.195 (-1.72%)

NVS Novartis
$86.30 /

-1.15 (-1.32%)

PODD Insulet
$216.60 /

-11.07 (-4.86%)

RHHBY Roche
$0.00 /

+ (+0.00%)

SNY Sanofi
$50.75 /

+0.15 (+0.30%)

TNDM TNDM
/

+

  • 13
    May
ABT Abbott
$100.91 /

-1.81 (-1.76%)

AMRN Amarin
$3.64 /

-0.035 (-0.95%)

AZN AstraZeneca
$54.18 /

-1.495 (-2.69%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

DXCM DexCom
$382.64 /

-2.39 (-0.62%)

GILD Gilead
$62.26 /

-0.85 (-1.35%)

LLY Eli Lilly
$148.89 /

-1 (-0.67%)

MDT Medtronic
$101.30 /

-0.52 (-0.51%)

MRK Merck
$83.17 /

+0.54 (+0.65%)

NVS Novartis
$86.30 /

-1.15 (-1.32%)

RHHBY Roche
$0.00 /

+ (+0.00%)

SNY Sanofi
$50.75 /

+0.15 (+0.30%)

ABT Abbott
$100.91 /

-1.81 (-1.76%)

AMRN Amarin
$3.64 /

-0.035 (-0.95%)

AZN AstraZeneca
$54.18 /

-1.495 (-2.69%)

BAYRY Bayer
$0.00 /

+ (+0.00%)

DXCM DexCom
$382.64 /

-2.39 (-0.62%)

GILD Gilead
$62.26 /

-0.85 (-1.35%)

LLY Eli Lilly
$148.89 /

-1 (-0.67%)

MDT Medtronic
$101.30 /

-0.52 (-0.51%)

MRK Merck
$83.17 /

+0.54 (+0.65%)

NVO Novo Nordisk
$68.25 /

-1.195 (-1.72%)

NVS Novartis
$86.30 /

-1.15 (-1.32%)

PODD Insulet
$216.60 /

-11.07 (-4.86%)

RHHBY Roche
$0.00 /

+ (+0.00%)

SNY Sanofi
$50.75 /

+0.15 (+0.30%)

TNDM TNDM
/

+

ABT Abbott
$100.91 /

-1.81 (-1.76%)

AMRN Amarin
$3.64 /

-0.035 (-0.95%)

AZN AstraZeneca
$54.18 /

-1.495 (-2.69%)

GILD Gilead
$62.26 /

-0.85 (-1.35%)

LLY Eli Lilly
$148.89 /

-1 (-0.67%)

MDT Medtronic
$101.30 /

-0.52 (-0.51%)

MRK Merck
$83.17 /

+0.54 (+0.65%)

NVO Novo Nordisk
$68.25 /

-1.195 (-1.72%)

SNY Sanofi
$50.75 /

+0.15 (+0.30%)

Conference/Events
Fluor to hold 2019 10K earnings conference call » 05:55
09/25/20
09/25
05:55
09/25/20
05:55
FLR

Fluor

$9.35 /

+0.865 (+10.19%)

Executive Chairman…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FLR Fluor
$9.35 /

+0.865 (+10.19%)

FLR Fluor
$9.35 /

+0.865 (+10.19%)

04/27/20 Citi
Fluor downgraded to Neutral from Buy at Citi
04/27/20 UBS
Fluor downgraded to Neutral from Buy at UBS
02/19/20
Fly Intel: Top five analyst downgrades
02/19/20 DA Davidson
Fluor price target lowered to $15 from $22 at DA Davidson
FLR Fluor
$9.35 /

+0.865 (+10.19%)

FLR Fluor
$9.35 /

+0.865 (+10.19%)

FLR Fluor
$9.35 /

+0.865 (+10.19%)

Recommendations
Accenture earnings weakness a buying opportunity, says Citi » 05:54
09/25/20
09/25
05:54
09/25/20
05:54
ACN

Accenture

$214.43 /

-16.16 (-7.01%)

Citi analyst Ashwin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ACN Accenture
$214.43 /

-16.16 (-7.01%)

ACN Accenture
$214.43 /

-16.16 (-7.01%)

09/22/20 UBS
Accenture assumed with a Neutral at UBS
09/22/20 Wedbush
Accenture price target raised to $255 from $240 at Wedbush
09/22/20 Piper Sandler
Accenture price target raised to $229 from $206 at Piper Sandler
09/21/20 BMO Capital
Accenture price target raised to $255 from $215 at BMO Capital
ACN Accenture
$214.43 /

-16.16 (-7.01%)

ACN Accenture
$214.43 /

-16.16 (-7.01%)

ACN Accenture
$214.43 /

-16.16 (-7.01%)

ACN Accenture
$214.43 /

-16.16 (-7.01%)

Syndicate
VIA Optronics 6.25M share IPO priced at $15.00 » 05:52
09/25/20
09/25
05:52
09/25/20
05:52
VIAO

VIA Optronics

$0.00 /

+ (+0.00%)

The deal range was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
  • 25
    Sep
Recommendations
WW price target lowered to $32 from $35 at Citi » 05:51
09/25/20
09/25
05:51
09/25/20
05:51
WW

WW

$18.23 /

-0.45 (-2.41%)

Citi analyst Wendy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
WW WW
$18.23 /

-0.45 (-2.41%)

WW WW
$18.23 /

-0.45 (-2.41%)

08/10/20 DA Davidson
WW price target lowered to $32 from $39 at DA Davidson
08/05/20 B. Riley FBR
WW price target raised to $36 from $30 at B. Riley FBR
06/17/20 Guggenheim
WW price target raised to $34 from $28 at Guggenheim
06/12/20 Guggenheim
WW initiated with a Buy at Guggenheim
WW WW
$18.23 /

-0.45 (-2.41%)

WW WW
$18.23 /

-0.45 (-2.41%)

WW WW
$18.23 /

-0.45 (-2.41%)

WW WW
$18.23 /

-0.45 (-2.41%)

Recommendations
Tupperware Brands price target raised to $28 from $15 at Citi » 05:50
09/25/20
09/25
05:50
09/25/20
05:50
TUP

Tupperware Brands

$23.70 /

-0.98 (-3.97%)

Citi analyst Wendy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
TUP Tupperware Brands
$23.70 /

-0.98 (-3.97%)

TUP Tupperware Brands
$23.70 /

-0.98 (-3.97%)

09/24/20 DA Davidson
Tupperware can stabilize core business, grow organic sales, says DA Davidson
09/15/20
Fly Intel: Top five analyst initiations
09/15/20 DA Davidson
Tupperware Brands initiated with a Buy at DA Davidson
08/17/20 Argus
Tupperware Brands upgraded to Hold from Sell at Argus
TUP Tupperware Brands
$23.70 /

-0.98 (-3.97%)

TUP Tupperware Brands
$23.70 /

-0.98 (-3.97%)

TUP Tupperware Brands
$23.70 /

-0.98 (-3.97%)

Recommendations
Jabil price target raised to $50 from $45 at Citi » 05:48
09/25/20
09/25
05:48
09/25/20
05:48
JBL

Jabil

$34.41 /

+2.04 (+6.30%)

Citi analyst Jim Suva…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JBL Jabil
$34.41 /

+2.04 (+6.30%)

JBL Jabil
$34.41 /

+2.04 (+6.30%)

09/18/20 Citi
Citi boosts Jabil target to $45 from $40, adds 'Catalyst Watch'
07/17/20 JPMorgan
Jabil price target raised to $43 from $40 at JPMorgan
07/16/20
Fly Intel: Top five analyst upgrades
07/15/20 Goldman Sachs
Jabil upgraded to Buy from Neutral at Goldman Sachs
JBL Jabil
$34.41 /

+2.04 (+6.30%)

Recommendations
Ibex price target lowered to $18 from $22 at Citi » 05:47
09/25/20
09/25
05:47
09/25/20
05:47
IBEX

Ibex

$10.95 /

+0.7 (+6.83%)

Citi analyst Ashwin…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
IBEX Ibex
$10.95 /

+0.7 (+6.83%)

IBEX Ibex
$10.95 /

+0.7 (+6.83%)

09/11/20 Piper Sandler
Ibex selloff brings valuation 'disconnect,' says Piper Sandler
09/01/20 Truist
Ibex initiated with a Buy at Truist
09/01/20 Baird
Baird starts Ibex with Outperform, sees above industry growth profile
09/01/20 Baird
Ibex initiated with an Outperform at Baird
IBEX Ibex
$10.95 /

+0.7 (+6.83%)

  • 07
    Aug
IBEX Ibex
$10.95 /

+0.7 (+6.83%)

Recommendations
Blue Cross Blue Shield settlement looks favorable for Anthem, says Citi » 05:45
09/25/20
09/25
05:45
09/25/20
05:45
ANTM

Anthem

$248.79 /

+3.3 (+1.34%)

The Wall Street Journal…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ANTM Anthem
$248.79 /

+3.3 (+1.34%)

ANTM Anthem
$248.79 /

+3.3 (+1.34%)

09/24/20 JPMorgan
JPMorgan says possible Blue Cross settlement could be positive for Anthem
09/21/20 Citi
Citi sees ACA remaining law despite Ginsburg death
07/01/20 SVB Leerink
Anthem reinstated with an Outperform at SVB Leerink
06/05/20 Goldman Sachs
Anthem initiated with a Neutral at Goldman Sachs
ANTM Anthem
$248.79 /

+3.3 (+1.34%)

ANTM Anthem
$248.79 /

+3.3 (+1.34%)

ANTM Anthem
$248.79 /

+3.3 (+1.34%)

Upgrade
Mizuho upgrades One Gas to Buy, says 26% pullback overdone » 05:41
09/25/20
09/25
05:41
09/25/20
05:41
OGS

One Gas

$67.13 /

+0.36 (+0.54%)

Mizuho analyst Gabriel…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OGS One Gas
$67.13 /

+0.36 (+0.54%)

05:12 Today Mizuho
One Gas upgraded to Buy from Neutral at Mizuho
08/20/20 UBS
One Gas upgraded to Buy from Neutral at UBS
08/11/20
Fly Intel: Top five analyst upgrades
08/11/20 Wells Fargo
One Gas upgraded to Overweight at Wells Fargo
OGS One Gas
$67.13 /

+0.36 (+0.54%)

Upgrade
Coty upgraded to Neutral from Sell at Citi » 05:38
09/25/20
09/25
05:38
09/25/20
05:38
COTY

Coty

$2.78 /

-0.14 (-4.79%)

Citi analyst Wendy…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COTY Coty
$2.78 /

-0.14 (-4.79%)

COTY Coty
$2.78 /

-0.14 (-4.79%)

09/24/20
Fly Intel: Top five analyst downgrades
09/24/20 Consumer Edge
Coty downgraded to Equal Weight from Overweight at Consumer Edge
08/31/20 DA Davidson
Coty price target lowered to $3.50 from $5.00 at DA Davidson
06/30/20 Jefferies
Jefferies says Coty 'needs to defy odds' for KKW deal to deliver sustained value
COTY Coty
$2.78 /

-0.14 (-4.79%)

COTY Coty
$2.78 /

-0.14 (-4.79%)

COTY Coty
$2.78 /

-0.14 (-4.79%)

COTY Coty
$2.78 /

-0.14 (-4.79%)

Initiation
Paradox Interactive initiated with a Neutral at Citi » 05:35
09/25/20
09/25
05:35
09/25/20
05:35
PRXXF

Paradox Interactive

$0.00 /

+ (+0.00%)

Citi analyst Thomas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PRXXF Paradox Interactive
$0.00 /

+ (+0.00%)

PRXXF Paradox Interactive
$0.00 /

+ (+0.00%)

08/10/20 Berenberg
Paradox Interactive price target raised to SEK 205 from SEK 180 at Berenberg
06/25/20 Jefferies
Paradox Interactive downgraded to Hold from Buy at Jefferies
05/14/20 Berenberg
Paradox Interactive upgraded to Hold from Sell at Berenberg
02/04/20 Berenberg
Paradox Interactive downgraded to Sell from Hold at Berenberg
PRXXF Paradox Interactive
$0.00 /

+ (+0.00%)

Initiation
Embracer Group initiated with a Buy at Citi » 05:34
09/25/20
09/25
05:34
09/25/20
05:34
THQQF

Embracer Group

$0.00 /

+ (+0.00%)

Citi analyst Thomas…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
THQQF Embracer Group
$0.00 /

+ (+0.00%)

08/25/20 SEB Equities
Embracer Group upgraded to Buy from Hold at SEB Equities
08/17/20 Berenberg
Embracer Group price target raised to SEK 185 from SEK 150 at Berenberg
07/29/20 SEB Equities
Embracer Group downgraded to Hold from Buy at SEB Equities
Initiation
Probe Metals initiated with an Outperformer at CIBC » 05:31
09/25/20
09/25
05:31
09/25/20
05:31
PROBF

Probe Metals

$0.00 /

+ (+0.00%)

CIBC analyst Alex Hunchak…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PROBF Probe Metals
$0.00 /

+ (+0.00%)

Initiation
Great Bear Resources initiated with an Outperformer at CIBC » 05:30
09/25/20
09/25
05:30
09/25/20
05:30
GTBAF

Great Bear Resources

$0.00 /

+ (+0.00%)

CIBC analyst Alex Hunchak…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GTBAF Great Bear Resources
$0.00 /

+ (+0.00%)

08/28/20 PI Financial
Great Bear Resources price target lowered to C$20.50 from C$21 at PI Financial
07/06/20 Canaccord
Great Bear Resources downgraded to Hold from Speculative Buy at Canaccord
06/19/20 Stifel
Great Bear Resources downgraded to Hold from Speculative Buy at Stifel GMP
Initiation
Marathon Gold initiated with an Outperformer at CIBC » 05:29
09/25/20
09/25
05:29
09/25/20
05:29
MGDPF

Marathon Gold

$0.00 /

+ (+0.00%)

CIBC analyst Alex Hunchak…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
Fifth Third upgraded to Overweight from Equal Weight at Morgan Stanley » 05:26
09/25/20
09/25
05:26
09/25/20
05:26
FITB

Fifth Third

$19.62 /

+0.06 (+0.31%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FITB Fifth Third
$19.62 /

+0.06 (+0.31%)

FITB Fifth Third
$19.62 /

+0.06 (+0.31%)

09/15/20 Piper Sandler
Fifth Third price target raised to $25 from $22 at Piper Sandler
07/31/20 Wolfe Research
Fifth Third initiated with an Outperform at Wolfe Research
07/29/20 Deutsche Bank
Fifth Third downgraded to Hold with $19 target at Deutsche Bank
07/28/20 Deutsche Bank
Fifth Third downgraded to Hold from Buy at Deutsche Bank
FITB Fifth Third
$19.62 /

+0.06 (+0.31%)

FITB Fifth Third
$19.62 /

+0.06 (+0.31%)

FITB Fifth Third
$19.62 /

+0.06 (+0.31%)

FITB Fifth Third
$19.62 /

+0.06 (+0.31%)

Upgrade
Antofagasta upgraded to Buy from Hold at Investec » 05:22
09/25/20
09/25
05:22
09/25/20
05:22
ANFGF

Antofagasta

$0.00 /

+ (+0.00%)

Investec analyst Hunter…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ANFGF Antofagasta
$0.00 /

+ (+0.00%)

09/24/20 Morgan Stanley
Antofagasta upgraded to Equal Weight amid return of inflation at Morgan Stanley
09/23/20 Morgan Stanley
Antofagasta upgraded to Equal Weight from Underweight at Morgan Stanley
09/15/20 Barclays
Antofagasta price target raised to 875 GBp from 725 GBp at Barclays
08/27/20 Investec
Antofagasta downgraded to Hold from Buy at Investec
Upgrade
Danieli & C. Officine Meccaniche upgraded to Buy from Hold at Kepler Cheuvreux » 05:21
09/25/20
09/25
05:21
09/25/20
05:21
DNIEF

Danieli & C. Officine Meccaniche

$0.00 /

+ (+0.00%)

Kepler Cheuvreux analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Initiation
EssilorLuxottica initiated with a Buy at Oddo BHF » 05:20
09/25/20
09/25
05:20
09/25/20
05:20
ESLOY

EssilorLuxottica

$0.00 /

+ (+0.00%)

Oddo BHF initiated…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ESLOY EssilorLuxottica
$0.00 /

+ (+0.00%)

08/04/20 RBC Capital
EssilorLuxottica price target lowered to EUR 115 from EUR 120 at RBC Capital
08/03/20 Deutsche Bank
EssilorLuxottica has left structure 'pretty much unchanged,' says Deutsche Bank
07/23/20 Berenberg
EssilorLuxottica initiated with a Buy at Berenberg
07/20/20 Bryan Garnier
EssilorLuxottica downgraded to Neutral from Buy at Bryan Garnier
ESLOY EssilorLuxottica
$0.00 /

+ (+0.00%)

Hot Stocks
Dr. Reddy's announces launch of Dexmedetomidine Hydrochloride injection » 05:19
09/25/20
09/25
05:19
09/25/20
05:19
RDY

Dr. Reddy's

$67.82 /

-0.79 (-1.15%)

Dr. Reddy's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RDY Dr. Reddy's
$67.82 /

-0.79 (-1.15%)

RDY Dr. Reddy's
$67.82 /

-0.79 (-1.15%)

09/18/20 Investec
Dr. Reddy's upgraded to Hold from Sell at Investec
09/03/20 Oppenheimer
Opco 'more skeptical' on Amarin patent win after 20 minute court hearing
09/02/20 Goldman Sachs
Oral arguments incrementally negative for Amarin, says Goldman Sachs
08/10/20 Oppenheimer
Amarin Perform rating affirmed at Oppenheimer after FDA approves Vascepa generic
RDY Dr. Reddy's
$67.82 /

-0.79 (-1.15%)

RDY Dr. Reddy's
$67.82 /

-0.79 (-1.15%)

Downgrade
Voltalia downgraded to Neutral from Buy at Oddo BHF » 05:19
09/25/20
09/25
05:19
09/25/20
05:19
VLTAF

Voltalia

$0.00 /

+ (+0.00%)

Oddo BHF analyst Philippe…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Upgrade
Targa Resources upgraded to Overweight from Underweight at Morgan Stanley » 05:18
09/25/20
09/25
05:18
09/25/20
05:18
TRGP

Targa Resources

$13.97 /

-0.05 (-0.36%)

Morgan Stanley analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TRGP Targa Resources
$13.97 /

-0.05 (-0.36%)

TRGP Targa Resources
$13.97 /

-0.05 (-0.36%)

08/19/20 BofA
Targa Resources reinstated with a Buy at BofA
08/14/20 Wolfe Research
Targa Resources upgraded to Peer Perform from Underperform at Wolfe Research
08/12/20 Mizuho
Targa Resources price target raised to $24 from $21 at Mizuho
07/27/20 Seaport Global
Targa Resources downgraded to Neutral from Buy at Seaport Global
TRGP Targa Resources
$13.97 /

-0.05 (-0.36%)

TRGP Targa Resources
$13.97 /

-0.05 (-0.36%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.